knowledge -WSS

knowledge

author：focus 2025-10-04 04:12:20 - browse：88832

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Websites selling Wegovy, Zepbound ingredients targeted by FDA

hotspot

WSS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Why Eli Lilly’s earnings didn’t quite live up to the hype

Latigo launches with $135 million for Vertex

WHO recommends dropping component of many flu vaccines

Juul documents reveal insider tactics on political lobbying

Biogen shutters digital health group, ends Apple study, in cost cutting move

focus

knowledge

focus

In Memoriam: Notable people who died in 2023

Menendez indictment could see pharma lose a key ally

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicaid, Medicare dual

Moonlake's readout produced a cash windfall. Risks remain

Eli Lilly reports tirzepatide MASH success during Q4 earnings

After affirmative action ruling, medical educators look to 'holistic review'

Covid vaccines: Private market messier than government rollout

Walensky prepares to leave CDC — and Congress — behind

Study gives hint on South Asians’ higher risk of cardiovascular disease

knowledge

Too many hospitalized Covid

Ionis has late

Why don't Americans have at

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

hotspot

hotspot

explore

leisure time